Concepedia

Peter D. Suzdak

PD

Statistics

Publications

65

Citations

5.6K

H-Index

36

Active since

1984

Affiliations

Novo Nordisk (Denmark)(Current)

National Institute of Mental Health

National Institutes of Health

University of Connecticut

Eli Lilly (United States)

Peter D. Suzdak is an author at Novo Nordisk (Denmark) specializing in neuropharmacology, pharmacology, and neuroscience.

Publications per year

1984–2001

65

Publications

65

Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes.

Peter D. Suzdak, Rochelle D. Schwartz, Phil Skolnick et al. · Proceedings of the National Academy of Sciences · 1986 · 546 citations · Full text

, , +16

A Selective Imidazobenzodiazepine Antagonist of Ethanol in the Rat

Peter D. Suzdak, John R. Glowa, Jacqueline N. Crawley et al. · Science · 1986 · 545 citations

, , +11

Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models

Joseph Steiner, Gregory S. Hamilton, Douglas T. Ross et al. · Proceedings of the National Academy of Sciences · 1997 · 327 citations

, , +17

Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency

A. Leslie Morrow, Peter D. Suzdak, Steven M. Paul · European Journal of Pharmacology · 1987 · 295 citations

, , +14

Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor

Erik B. Nielsen, Peter D. Suzdak, Knud Erik Andersen et al. · European Journal of Pharmacology · 1991 · 232 citations

, , +13

1–5 of 65